Michael E Ohl
Overview
Explore the profile of Michael E Ohl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ohl M, Miell K, Beck B, Mecham B, Bailey G, Mengeling M, et al.
JAMA Netw Open
. 2023 May;
6(5):e2315902.
PMID: 37252740
Importance: Veterans Health Administration (VHA) enrollees receive care for COVID-19 in both VHA and non-VHA (ie, community) hospitals, but little is known about the frequency or outcomes of care for...
3.
Suzuki H, Goto M, Nair R, Livorsi D, Sekar P, Ohl M, et al.
Open Forum Infect Dis
. 2022 Oct;
9(9):ofac473.
PMID: 36196299
Background: Rifampin is recommended as adjunctive therapy for patients with a prosthetic joint infection (PJI) managed with debridement, antibiotics, and implant retention (DAIR), with no solid consensus on the optimal...
4.
Suzuki H, Marra A, Hasegawa S, Livorsi D, Goto M, Perencevich E, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Sep;
1(1):e24.
PMID: 36168456
Objective: To evaluate the frequency of antibiotic prescribing for common infections via telemedicine compared to face-to-face visits. Design: Systematic literature review and meta-analysis. Methods: We searched PubMed, CINAHL, Embase (Elsevier...
5.
Crothers K, DeFaccio R, Tate J, Alba P, Goetz M, Jones B, et al.
Eur Respir J
. 2021 Nov;
60(1).
PMID: 34824060
Background: Dexamethasone decreases mortality in coronavirus disease 2019 (COVID-19) patients on intensive respiratory support (IRS) but is of uncertain benefit if less severely ill. We determined whether early (within 48 ...
6.
Chasco E, Shafer C, Dillon D, Owens S, Ohl M, Hoth A
Am J Prev Med
. 2021 Oct;
61(5 Suppl 1):S108-S117.
PMID: 34686280
Introduction: Regional partnerships between public health organizations and telehealth programs have the potential to expand access to HIV pre-exposure prophylaxis in rural and small urban areas. However, little is known...
7.
Kobayashi T, Van Epps P, Maier M, Beste L, Beck B, Alexander B, et al.
J Gen Intern Med
. 2021 Aug;
37(10):2482-2488.
PMID: 34341917
Background: Healthcare encounters for the diagnosis and treatment of sexually transmitted infections (STIs) are common and represent an opportunity to discuss and initiate HIV pre-exposure prophylaxis (PrEP). Little is known...
8.
Ohl M, Miller D, Lund B, Kobayashi T, Miell K, Beck B, et al.
JAMA Netw Open
. 2021 Jul;
4(7):e2114741.
PMID: 34264329
Importance: Randomized clinical trials have yielded conflicting results about the effects of remdesivir therapy on survival and length of hospital stay among people with COVID-19. Objective: To examine associations between...
9.
Bokhour B, Bolton R, Asch S, Dvorin K, Fix G, Gifford A, et al.
Med Care
. 2021 Apr;
59(8):727-735.
PMID: 33900271
Background: With human immunodeficiency virus (HIV) now managed as a chronic disease, health care has had to change and expand to include management of other critical comorbidities. We sought to...
10.
Chasco E, Hoth A, Cho H, Shafer C, Siegler A, Ohl M
AIDS Behav
. 2021 Mar;
25(8):2463-2482.
PMID: 33740212
Home specimen self-collection kits with central laboratory testing may improve persistence with PrEP and enhance telehealth programs. We offered Iowa TelePrEP clients the choice of using a home kit or...